Vega, Lorena R.

HRN: 17-79-12  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/22/2026
METRONIDAZOLE 500MG (TAB)
07/22/2026
07/28/2026
ORAL
500mg
Q8hr
Thickly MSAF
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: